Human cell culture assays for EGFP knockdown were performed essentially as described previously7, but with the following modifications. The X-001 program was used on a Lonza 2b nucleofector, and reaction mixtures were accordingly scaled up to 500,000 cells with 2000 ng Cas9 plasmid, 666 ng sgRNA plasmid, and 80 ng ptdTomato. Cells were harvested 52 h post transfection and then kept on ice, but were analyzed on a SONY SH800 cell cytometer with 20,000 events captured per sample. The percentage of EGFP-negative cells in each sample was determined from a subpopulation after gating for the top ~50% of tdTomato-expressing cells; the tdTomato-expressing population was identified by comparing control samples that were untransfected or transfected with ptdTomato alone. Each Cas9/sgRNA combination was tested in quadruplicate by performing two biological duplicates on separate days. Finally, a global average of 3.39% background EGFP loss (denoted with a black dashed line) was estimated from four biological duplicate experiments with a non-targeting sgRNA plasmid (BPK1520) performed on four separate days. The clonal U2OS.EGFP cell line used for these assays was obtained from the Joung lab, and harbors a constitutively expressed hEGFP cassette integrated in the genome49.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.